UPDATE 3-Amneal, Impax combine to tackle generic drug pricing pressure By: Reuters: Company News October 17, 2017 at 12:11 PM EDT * Impax was expected to keep >25 pct stake - analyst (Adds analysts' comments, background on retail pharmacies; updates shares) Read More >> Related Stocks: Allergan Plc Endo Int'l Plc Morgan Stanley Teva Pharmaceutical Industries ADR